Results
76,380 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 |  Field DylanDirector, President & CEO, 10% Owner |  FIGFigma, Inc.Derivative conversion · 10b5-1 plan | C | — 174.4K sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Field DylanDirector, President & CEO, 10% Owner | FIGFigma, Inc. Derivative conversion · 10b5-1 plan | C | — 174.4K sh |
| Jun 2, 2026 traded May 29, 2026 |
| 3 | Dandekar AtulCSBO |  MAZEMaze Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $78K 7,500 sh | Jun 2, 2026 traded May 29, 2026 |
| 2 | Reardon AndrewCLO & Secretary |  LGNDLIGAND PHARMACEUTICALS INCOption exercise · 10b5-1 plan | M | $261K 5,000 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 1 | Arora TarunChief Accounting Officer |  RNGRingCentral, Inc.Open-market sale · 10b5-1 plan | SELL | $109K 2,515 sh | Jun 2, 2026 traded May 29, 2026 |
| 1 | Rezvan MitraChief Accounting Officer |  SAILSailPoint, Inc.Open-market sale · 10b5-1 plan | SELL | $150K 7,487 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | FIGFigma, Inc. Derivative conversion · 10b5-1 plan | C | — 174.4K sh | Jun 2, 2026 traded May 29, 2026 |
| 0 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 5,000 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D |  DNTHDianthus Therapeutics, Inc. /DE/Option exercise · 10b5-1 plan | M | — 3,998 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Delaet IngridChief Regulatory Officer |  NBIXNEUROCRINE BIOSCIENCES INCOption exercise · 10b5-1 plan | M | — 2,261 sh | Jun 2, 2026 traded May 29, 2026 |
| 0 | Arora TarunChief Accounting Officer | RNGRingCentral, Inc. Open-market sale · 10b5-1 plan | SELL | $46K 1,100 sh | Jun 2, 2026 traded May 29, 2026 |
| 0 | McGrane AshleyGeneral Counsel and Corp Sec |  GTMZoomInfo Technologies Inc.Option exercise · 10b5-1 plan | M | — 206 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Arora TarunChief Accounting Officer | RNGRingCentral, Inc. Tax withholding · 10b5-1 plan | F | $212K 4,322 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Arora TarunChief Accounting Officer | RNGRingCentral, Inc. Grant or award · 10b5-1 plan | A | — 25.7K sh | Jun 2, 2026 traded May 29, 2026 |
| 0 | McGrane AshleyGeneral Counsel and Corp Sec | GTMZoomInfo Technologies Inc. Tax withholding · 10b5-1 plan | F | $230 69 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Roth James MChief Revenue Officer | GTMZoomInfo Technologies Inc. Option exercise · 10b5-1 plan | M | — 344 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Roth James MChief Revenue Officer | GTMZoomInfo Technologies Inc. Option exercise · 10b5-1 plan | M | — 387 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Ber HedvaGlobal COO & Deputy CEO |  ETOReToro Group Ltd.Option exercise · 10b5-1 plan | M | — 6,000 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 6,249 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Roth James MChief Revenue Officer | GTMZoomInfo Technologies Inc. Option exercise · 10b5-1 plan | M | — 387 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Ber HedvaGlobal COO & Deputy CEO | ETOReToro Group Ltd. Option exercise · 10b5-1 plan | M | — 6,000 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Jeddi ImanSVP & GM da Vinci Platforms & |  ISRGINTUITIVE SURGICAL INCOption exercise · 10b5-1 plan | M | — 5,625 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Ber HedvaGlobal COO & Deputy CEO | ETOReToro Group Ltd. Option exercise · 10b5-1 plan | M | — 22.5K sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | McGrane AshleyGeneral Counsel and Corp Sec | GTMZoomInfo Technologies Inc. Grant or award · 10b5-1 plan | A | — 393.8K sh | Jun 2, 2026 traded May 29, 2026 |
| 0 | Roth James MChief Revenue Officer | GTMZoomInfo Technologies Inc. Tax withholding · 10b5-1 plan | F | $1,102 331 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 6,908 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 7,500 sh | Jun 2, 2026 traded May 29, 2026 |
| 0 | Roth James MChief Revenue Officer | GTMZoomInfo Technologies Inc. Grant or award · 10b5-1 plan | A | — 647.5K sh | Jun 2, 2026 traded May 29, 2026 |
| 0 | Hamilton Brian TDirector, President of CCBX |  CCBCOASTAL FINANCIAL CORPTax withholding · 10b5-1 plan | F | $16K 230 sh | Jun 2, 2026 traded Jun 2, 2026 |
| 0 | Ber HedvaGlobal COO & Deputy CEO | ETOReToro Group Ltd. Option exercise · 10b5-1 plan | M | — 20.7K sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 9,375 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 55 | Slusky Alexander RDirector |  RKLBRocket Lab CorpOpen-market sale | SELL | $5.96M 40.0K sh | Jun 1, 2026 traded May 28, 2026 |
| 55 | Slusky Alexander RDirector | RKLBRocket Lab Corp Open-market sale | SELL | $3.00M 20.0K sh | Jun 1, 2026 traded May 28, 2026 |
| 45 | Abbey WilliamChief Commercial Officer |  ARMARM HOLDINGS PLC /UKOpen-market sale | SELL | $1.44M 4,200 sh | Jun 1, 2026 traded May 28, 2026 |
| 45 | Clevenger Marvin BradfordPresident, Rocket Lab USA, Inc | RKLBRocket Lab Corp Open-market sale | SELL | $513K 3,500 sh | Jun 1, 2026 traded May 28, 2026 |
| 45 | Ben-Avi DavidDirector, CTO and Co Founder |  NYAXNayax Ltd.Open-market sale | SELL | $1.02M 13.6K sh | Jun 1, 2026 traded May 28, 2026 |
| 44 | Stetson Glenn WEVP and COO |  MTDRMatador Resources CoOpen-market purchase | BUY | $27K 500 sh | Jun 1, 2026 traded May 28, 2026 |
| 42 | Jacobson SamanthaDirector |  TTDTrade Desk, Inc.Open-market sale | SELL | $1.13M 53.7K sh | Jun 1, 2026 traded May 28, 2026 |
| 42 | Cunningham LyleChief Banking Officer |  CUBICustomers Bancorp, Inc.Open-market sale | SELL | $3.59M 47.9K sh | Jun 1, 2026 traded May 29, 2026 |
| 41 | Ben-Avi DavidDirector, CTO and Co Founder | NYAXNayax Ltd. Open-market sale | SELL | $1.27M 16.6K sh | Jun 1, 2026 traded May 29, 2026 |
| 39 |  Daniel WebsterRSelf |  REXRRexford Industrial Realty, Inc.Sale | SELL | $15K – $50K | Jun 1, 2026 traded Feb 26, 2025 |